NEBRASKA CENTER FOR NANOMEDICINE ADMINISTRATIVE CORE
NEBRASKA CENTER FOR NANOMEDICINE ADMINISTRATIVE CORE
批准号:
8360236
负责人:
ALEXANDER V KABANOV
金额:
$66.62万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-01 至 2012-06-30
关键词:
AddressAdverse effectsAreaAwardBiomedical ResearchCancer BiologyCenters of Research ExcellenceClinicalDevelopmentDevicesDiseaseDrug Delivery SystemsEarly DiagnosisFoundationsFundingGene DeliveryGoalsGrantImmunizationImmunologyMapsMedical centerNanotechnologyNational Center for Research ResourcesNebraskaNeurosciencesPathologyPharmaceutical PreparationsPharmacologyPolymersPrincipal InvestigatorRecombinant DNAResearchResearch ActivityResearch InfrastructureResourcesScienceSourceTechniquesTranslatingUnited States National Institutes of HealthUniversitiesbioimagingcostimprovednanomaterialsnanomedicinenanoscalenext generationtumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources
provided by a Center grant funded by NIH/NCRR. Primary support for the subproject
and the subproject's principal investigator may have been provided by other sources,
including other NIH sources. The Total Cost listed for the subproject likely
represents the estimated amount of Center infrastructure utilized by the subproject,
not direct funding provided by the NCRR grant to the subproject or subproject staff.
The Nebraska Center for Nanomedicine (NCN), a Center of Biomedical Research Excellence (COBRE) has been created from this award. Nanomedicine is a rapidly developing area of biomedical research that uses devices of nanoscale size to address urgent needs for improved drug and gene delivery. Such "next generation" therapies can specifically deliver drugs and recombinant DNAs to focal areas of disease or to tumors to maximize clinical benefit while limiting untoward side effects. Such nanotechnologies are expected to drastically improve early diagnosis through bioimaging techniques. This parallels the road map for the National Institutes of Health (NIH) where nanomedicine was identified as a development initiative for the next decade. In keeping with these ideas, the Center will serve to join already strong areas of biomedical and material science research into an even stronger unit. Such goals can now be realized with the established expertise in biomedical sciences (neuroscience, pathology, immunology, pharmacology, immunization and cancer biology) and those in the material sciences (nanomaterials, polymers, drug delivery, and gene delivery) within the University of Nebraska Medical Center (UNMC). The primary goal of the Center is to provide a foundation for synergistic research activities and translating the efforts into clinical benefit for diseases with limited treatment options while simultaneously developing a potentially "visionary" area of science where the State of Nebraska can emerge as a world-leader.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Naturally Targeted Exosomal TLR7/8 Agonist for Immunotherapy of Medulloblastoma
-
批准号:10790660
-
项目类别:
-
资助金额:$42.76万
-
财政年份:2023
-
负责人:ALEXANDER V KABANOV
-
依托单位:
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
-
批准号:10436355
-
项目类别:
-
资助金额:$60.08万
-
财政年份:2021
-
负责人:ALEXANDER V KABANOV
-
依托单位:
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
-
批准号:10684815
-
项目类别:
-
资助金额:$49.63万
-
财政年份:2021
-
负责人:ALEXANDER V KABANOV
-
依托单位:
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
-
批准号:10621403
-
项目类别:
-
资助金额:$11.79万
-
财政年份:2021
-
负责人:ALEXANDER V KABANOV
-
依托单位:
TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
-
批准号:10306113
-
项目类别:
-
资助金额:$61.31万
-
财政年份:2021
-
负责人:ALEXANDER V KABANOV
-
依托单位:
Diversity Supplement - TOWARD TRANSLATION OF NANFORMULATED PACLITAXEL-PLATINUM COMBINATION
-
批准号:10529457
-
项目类别:
-
资助金额:$5.01万
-
财政年份:2021
-
负责人:ALEXANDER V KABANOV
-
依托单位:
2017 Cancer Nanotechnology Gordon Research Conference and Gordon Research Seminar
-
批准号:9260177
-
项目类别:
-
资助金额:$0.25万
-
财政年份:2017
-
负责人:ALEXANDER V KABANOV
-
依托单位:
Targeted Magneto-Mechanic Nanotherapeutics for Cancer
-
批准号:9382042
-
项目类别:
-
资助金额:$11.76万
-
财政年份:2017
-
负责人:ALEXANDER V KABANOV
-
依托单位:
Targeted Magneto-Mechanic Nanotherapeutics for Cancer
-
批准号:9751229
-
项目类别:
-
资助金额:$11.38万
-
财政年份:2017
-
负责人:ALEXANDER V KABANOV
-
依托单位:
Nasal Leptin - Polymer Conjugate for Treatment of Obesity
-
批准号:9140512
-
项目类别:
-
资助金额:$21.58万
-
财政年份:2016
-
负责人:ALEXANDER V KABANOV
-
依托单位:
CAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP)
-
批准号:10650745
-
项目类别:
-
资助金额:$38.86万
-
财政年份:2015
-
负责人:ALEXANDER V KABANOV
-
依托单位:
CAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP)
-
批准号:8934892
-
项目类别:
-
资助金额:$20.08万
-
财政年份:2015
-
负责人:ALEXANDER V KABANOV
-
依托单位:
Nanoformulation of the BDNF for treatment of stroke
-
批准号:9139992
-
项目类别:
-
资助金额:$37.21万
-
财政年份:2015
-
负责人:ALEXANDER V KABANOV
-
依托单位:
Liposomal Doxorubicin and Pluronic Combination for Cancer Therapy
-
批准号:8991307
-
项目类别:
-
资助金额:$34.45万
-
财政年份:2015
-
负责人:ALEXANDER V KABANOV
-
依托单位:
CAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP)
-
批准号:10024629
-
项目类别:
-
资助金额:$46.71万
-
财政年份:2015
-
负责人:ALEXANDER V KABANOV
-
依托单位:
CAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP)
-
批准号:10452492
-
项目类别:
-
资助金额:$42.13万
-
财政年份:2015
-
负责人:ALEXANDER V KABANOV
-
依托单位:
Liposomal Doxorubicin and Pluronic Combination for Cancer Therapy
-
批准号:9206144
-
项目类别:
-
资助金额:$34.45万
-
财政年份:2015
-
负责人:ALEXANDER V KABANOV
-
依托单位:
CAROLINA CANCER NANOTECHNOLOGY TRAINING PROGRAM (C-CNTP)
-
批准号:10212976
-
项目类别:
-
资助金额:$42.47万
-
财政年份:2015
-
负责人:ALEXANDER V KABANOV
-
依托单位:
NEW HIRES
-
批准号:8360242
-
项目类别:
-
资助金额:$29.74万
-
财政年份:2011
-
负责人:ALEXANDER V KABANOV
-
依托单位:
NANOMATERIALS
-
批准号:8360241
-
项目类别:
-
资助金额:$14.87万
-
财政年份:2011
-
负责人:ALEXANDER V KABANOV
-
依托单位:
海外基金